share_log

京東健康：截至二零二四年一月三十一日止月份之股份發行人的證券變動月報表

JD HEALTH: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2024

香港交易所 ·  Feb 6 16:57
Summary by Futu AI
京东健康股份有限公司於2024年2月6日向香港交易及結算所有限公司提交了最新的證券變動月報表，涵蓋截至2024年1月31日的資料。報告顯示，公司的法定/註冊股本及已發行股份在該月份內無變動，維持在100,000,000,000股普通股，每股面值0.0000005美元，總股本為50,000美元。此外，根據首次公開發售前員工股權激勵計劃，本月內有158,809股份期權被行使，而6,624,068股份期權失效，但由於股份期權是以股份償付，因此無需發行新股份。報告亦提及，根據首次公開發售後股份獎勵計劃，本月底可能發行的發行人新股份數目為30,551,700股。公司確認所有證券發行均已獲董事會批准，並符合香港聯合交易所有限公司證券上市規則的要求。
京东健康股份有限公司於2024年2月6日向香港交易及結算所有限公司提交了最新的證券變動月報表，涵蓋截至2024年1月31日的資料。報告顯示，公司的法定/註冊股本及已發行股份在該月份內無變動，維持在100,000,000,000股普通股，每股面值0.0000005美元，總股本為50,000美元。此外，根據首次公開發售前員工股權激勵計劃，本月內有158,809股份期權被行使，而6,624,068股份期權失效，但由於股份期權是以股份償付，因此無需發行新股份。報告亦提及，根據首次公開發售後股份獎勵計劃，本月底可能發行的發行人新股份數目為30,551,700股。公司確認所有證券發行均已獲董事會批准，並符合香港聯合交易所有限公司證券上市規則的要求。
KYOTO HEALTH CO., LTD. FILED ITS LATEST MONTHLY SECURITIES CHANGE REPORT WITH HONG KONG TRADING AND SETTLEMENT LIMITED ON FEBRUARY 6, 2024, COVERING DATA AS OF JANUARY 31, 2024. The report shows that the company's regulary/registered share capital and issued shares remained unchanged during the month at 100,000,000,000 shares of ordinary shares with a face value of $0.00005 per share and a total share capital of $50,000. In addition, under the Employee Stock Incentive Scheme prior to the initial public offering, 158,809 share options were exercised during the month and 6,624,068 share options expired, but no new shares were required to be issued since the share options were paid in shares. The report also notes that under the Initial Public Offering Share Award Scheme, the number of issuer new shares that may be issued at the end of this month is 30,551,700 shares. The Company confirms that all securities issuance has been approved by the Board of Directors and complies with the requirements of the Securities Listing Rules of the Hong Kong Stock Exchange Limited.
KYOTO HEALTH CO., LTD. FILED ITS LATEST MONTHLY SECURITIES CHANGE REPORT WITH HONG KONG TRADING AND SETTLEMENT LIMITED ON FEBRUARY 6, 2024, COVERING DATA AS OF JANUARY 31, 2024. The report shows that the company's regulary/registered share capital and issued shares remained unchanged during the month at 100,000,000,000 shares of ordinary shares with a face value of $0.00005 per share and a total share capital of $50,000. In addition, under the Employee Stock Incentive Scheme prior to the initial public offering, 158,809 share options were exercised during the month and 6,624,068 share options expired, but no new shares were required to be issued since the share options were paid in shares. The report also notes that under the Initial Public Offering Share Award Scheme, the number of issuer new shares that may be issued at the end of this month is 30,551,700 shares. The Company confirms that all securities issuance has been approved by the Board of Directors and complies with the requirements of the Securities Listing Rules of the Hong Kong Stock Exchange Limited.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

The translation is provided by third-party software.


The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.